M&A: Page 2
-
Hologic to buy Endomagnetics for $310M
Endomagnetics, which makes guidance technology for breast cancer surgery, brought in about $35 million in revenue last year.
By Elise Reuter • April 30, 2024 -
Labcorp to acquire Invitae’s assets for $239M
William Blair analyst Andrew Brackmann said Labcorp is being aggressive in its M&A strategy, after announcing last month it would buy several of Bioreference Health’s testing businesses.
By Susan Kelly • April 25, 2024 -
Cancer test maker Dermtech to cut 100 jobs, explore strategic options
Dermtech, which will not hold a first-quarter earnings call, said the layoffs are part of a broader effort to “significantly reduce” expenses.
By Susan Kelly • April 19, 2024 -
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
After J&J’s $13.1 billion purchase of Shockwave Medical, Moody’s analysts see the potential for other larger pick-ups “if interest rates substantially decrease.”
By Nick Paul Taylor • April 19, 2024 -
Bruker to acquire Nanostring for $393M
Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.
By Susan Kelly • April 18, 2024 -
Steris to sell dental segment for $787.5M
Divesting the business will allow Steris to repay debt and focus on its core markets of healthcare, pharma and medtech.
By Elise Reuter • April 11, 2024 -
J&J to acquire Shockwave Medical for $13.1B
The deal comes just over a week after The Wall Street Journal reported that the companies were discussing a merger.
By Ricky Zipp • Updated April 5, 2024 -
Retrieved from Axonics on August 22, 2023
FTC asks Boston Scientific for more info on $3.7B Axonics deal
The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission.
By Susan Kelly • April 4, 2024 -
3M spins out Solventum
The new company will need to work through debt from the spinoff and sole-source arrangements with 3M.
By Elise Reuter • April 1, 2024 -
Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets
The acquired assets generate about $100 million in annual revenue, according to the deal announcement.
By Nick Paul Taylor • March 29, 2024 -
J&J’s $13.1B offer for Shockwave vaults to top of medtech M&A list in 2024
Johnson & Johnson’s proposal for Shockwave Medical replaced Boston Scientific’s $3.7 billion offer for Axionics as the priciest medical device deal this year.
By Ricky Zipp • Updated May 10, 2024 -
J&J in talks to buy Shockwave Medical: WSJ
The healthcare giant could follow up its $16.6 billion acquisition of Abiomed with another deal for a heart device company, the WSJ reported Tuesday.
By Ricky Zipp • March 27, 2024 -
Johnson Matthey to sell medical device components unit for $700M
The segment makes components for medical devices, such as nitinol and metallic coatings.
By Elise Reuter • March 20, 2024 -
Retrieved from Titan on September 12, 2022
Titan Medical to merge with imaging firm Conavi, ending strategic review
The combined company will focus on selling Conavi’s cardiovascular imaging system used in minimally invasive procedures.
By Elise Reuter • March 19, 2024 -
Haemonetics to buy Attune Medical for $160M
Attune’s device to help cool the esophagus during radiofrequency ablation procedures is a key piece of the acquisition.
By Susan Kelly • March 5, 2024 -
Baxter considers selling kidney care unit to private equity
The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.
By Elise Reuter • March 4, 2024 -
Agiliti to go private in $2.5B PE deal
After the transaction’s expected close in the first half of this year, Agiliti will no longer trade on the New York Stock Exchange.
By Susan Kelly • Feb. 26, 2024 -
Ex-Mazor exec convicted of insider trading conspiracy linked to $1.6B Medtronic deal
A federal jury found Doron Tavlin guilty on one count of conspiracy to commit insider trading and 10 counts related to securities fraud.
By Nick Paul Taylor • Feb. 22, 2024 -
The top medtech trends in 2024
Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.
By MedTech Dive Staff • Jan. 31, 2024 -
Cook Medical sells ear, nose and throat devices to C2Dx
The transaction completes Cook’s divestiture of its otolaryngology, head and neck surgery product lines.
By Nick Paul Taylor • Jan. 26, 2024 -
Invitae sells reproductive health assets amid liquidity concerns
DNA testing firm Natera could pay up to $52.5 million total, and plans to move Invitae’s customers to its own tests.
By Elise Reuter • Jan. 22, 2024 -
Integer acquires Pulse Technologies for $140M
Pulse specializes in the micro machining of components for medical devices used in markets such as structural heart.
By Nick Paul Taylor • Jan. 16, 2024 -
Deep Dive
5 medtech trends to watch in 2024
From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.
By Ricky Zipp • Jan. 9, 2024 -
Retrieved from Axonics on August 22, 2023
Boston Scientific to buy Axonics for $3.7B to gain incontinence treatment
The acquisition provides a high-growth addition to Boston Scientific’s urology business, analysts said.
By Susan Kelly • Jan. 8, 2024 -
Q&A
‘Healthy pullback’: GSR Ventures’ Sunny Kumar on normalizing digital health funding, accelerating M&A in 2024
Sunny Kumar discusses digital healthcare investment, the landscape for M&A and when the public markets could open back up.
By Emily Olsen • Jan. 8, 2024